Eli, Lillys

Eli Lilly's Donanemab Approval Heats Up Alzheimer's Disease Treatment Market | DelveInsight

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/eli-lillys-donanemab-approval-heats-up-alzheimers-disease-treatment-market--delveinsight-302190544.html

en | boerse | 67927664 |